MILLENNIUM MANAGEMENT LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 62 filers reported holding UROGEN PHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,863,748
+94.3%
275,785
+43.5%
0.00%
+100.0%
Q2 2023$1,988,525
+60562.8%
192,128
-45.8%
0.00%
-50.0%
Q1 2023$3,278
+33.3%
354,776
+28.0%
0.00%
+100.0%
Q4 2022$2,459
-99.9%
277,248
-36.9%
0.00%
-50.0%
Q3 2022$3,657,000
-27.5%
439,522
-28.7%
0.00%
-33.3%
Q2 2022$5,047,000
+269.2%
616,245
+292.8%
0.00%
+200.0%
Q1 2022$1,367,000
+112.9%
156,904
+132.5%
0.00%
Q4 2021$642,000
-44.4%
67,492
-1.7%
0.00%
-100.0%
Q3 2021$1,155,000
+18.6%
68,687
+7.7%
0.00%0.0%
Q2 2021$974,000
-32.6%
63,800
-14.0%
0.00%0.0%
Q1 2021$1,445,000
+12.1%
74,201
+3.7%
0.00%0.0%
Q4 2020$1,289,000
-25.5%
71,522
-20.3%
0.00%
-50.0%
Q3 2020$1,730,000
-37.7%
89,708
-15.6%
0.00%
-50.0%
Q2 2020$2,776,000
+976.0%
106,279
+879.1%
0.00%
Q3 2019$258,000
-92.1%
10,855
-88.0%
0.00%
-100.0%
Q2 2019$3,248,000
-12.0%
90,368
-9.5%
0.01%
-16.7%
Q1 2019$3,690,000
-22.0%
99,894
-9.1%
0.01%
-14.3%
Q4 2018$4,732,000
-57.1%
109,892
-52.9%
0.01%
-50.0%
Q3 2018$11,021,000
+28.5%
233,353
+35.4%
0.01%
+27.3%
Q2 2018$8,575,000
+8.5%
172,332
+8.3%
0.01%0.0%
Q1 2018$7,906,000
+1751.5%
159,113
+1285.4%
0.01%
+1000.0%
Q4 2017$427,00011,4850.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders